What does Biomedicines do?

Sail Biomedicines is a biotechnology company based in Somerville, Massachusetts, founded in 2023. The company specializes in developing programmable RNA medicines using its proprietary Endless RNA™ (eRNA™) technology, targeted nanoparticles (TNPs), and artificial intelligence. Sail Biomedicines aims to create next-generation RNA therapeutics that address the limitations of conventional mRNA therapies, focusing on autoimmune, metabolic, infectious, and rare diseases. The company's innovative platform combines first-in-class circular RNA for enhanced stability and performance with modular targeted nanoparticles designed for precise delivery. Sail's generative AI algorithms optimize the design of RNA and nanoparticle components, enabling rapid scalability and superior performance. Currently, Sail is advancing eRNA™-TNP medicines through preclinical programs, including a candidate targeting Ornithine Carbamoyltransferase (OTC) Deficiency Disease. The company is backed by investors such as Flagship Pioneering and the Bill & Melinda Gates Foundation, emphasizing its commitment to impactful healthcare solutions.